Form D Explorer

Source evidence

InterAct Therapeutics, Inc. · 0002107143-26-000001

D filed July 21, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
DALLAS
street1
3060 PEGASUS PARK DRIVE
street2
BUILDING 6
zipCode
75247
entityName
InterAct Therapeutics, Inc.
entityType
Corporation
stateOrCountry
TX
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold250000number250000/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount2000000number2000000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count1number1/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 39a03c594c348eecff9b43c74d0c942d952b6db3f069ce8109b1e759f08bc57a. This proves extraction identity, not the accuracy of the filer's claims.